U.S. federal trademark · Serial No. 98054545
Design and testing for new cell products namely, natural killer cell, gamma delta T cell, stem cell, and other cell products; Platform as a service (PAAS) featuring computer software platforms for developing cell products to improve ability to target tumor cells or other abnormal cells; Platform as a service (PAAS) featuring computer software platforms for use with cell therapy to manufacture tumor targeted or abnormal cell targeted cell products for use in the prevention and treatment of cancer, tumors, hematologic disease, solid cancers, hyperproliferative disease, autoimmune disease, neuronal diseases, hematopoietic cell-related diseases, metabolic syndrome, infectious diseases, immune disease or disorder, and other diseases or disorders; Providing medical and scientific research information in the field of cells and cell-derived preparations; Providing a web site featuring technology that enables users to present products in the fields of cell therapy and regenerative medicine services to others for comment and gather feedback from those others about those products
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.